Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.
about
Options for perioperative pain management in neurosurgery.Gabapentin treatment for bipolar disorders.Potential interaction between ritonavir and carbamazepine.Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.Gabapentin in the treatment of neuropathic pain.Use of lamotrigine to augment clozapine in patients with resistant schizophrenia and comorbid alcohol dependence: a potent anti-craving effect?Pregabalin: a new neuromodulator with broad therapeutic indications.Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for cliniciansBilateral SUNCT syndrome associated to chronic maxillary sinus disease.Oxcarbazepine in the treatment of bipolar disorder: a review.Pharmacokinetics, toxicology and safety of lamotrigine in epilepsy.Administration of four different doses of gabapentin reduces awakening from breakthrough pain and adverse effects in outpatients with neuropathic pain during the initial titrationTreatment of refractory complex partial seizures: role of vigabatrin.Gabapentin in acute postoperative pain managementPharmacokinetic aspects of the anti-epileptic drug substance vigabatrin: focus on transporter interactions.Pharmacokinetic interaction between retigabine and lamotrigine in healthy subjects.Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures.Effect of vigabatrin and gabapentin on phynytoin pharmacokinetics in the dog.
P2860
Q26765269-631FA549-4332-4E98-A207-1213DDE64700Q34417311-EB4F0482-204C-464D-8B8E-F7D90D9C08E4Q34509811-B10C6C89-9B5F-4834-8D4D-A7E9A58884BCQ35175895-B2928FB9-8620-4003-8023-46ECA46D6480Q35674900-96A222A8-B652-445A-AE0D-66C4153E52DFQ36124299-FF0C5063-0FD4-4069-A592-0240A3A4A971Q36313119-B7E4B6FC-B45A-4055-A995-58FAA6015314Q36515513-C617E79C-1888-49C9-8185-C44708D3F586Q36569400-97B5DE2E-16DD-4F4B-B60D-FB4437BF73C5Q36577870-F5724CB4-EA18-4234-AE85-26C6D31E6E40Q36662898-9C43EC93-D2B4-4746-9AFF-5C4FE7809A4AQ37054266-C6539873-D92C-42C7-9FF1-04F92C737AD6Q37620193-AEE36DC3-F3CF-4E03-B118-317CFAB01BF7Q38211875-81FFFC8E-A0C4-4084-8365-03976395A64FQ38261962-5779A530-1E33-4EEE-812A-7914F338264CQ44405609-2A32ACC8-CF75-4413-ADB4-9DD61DFFAFEAQ51512695-7D93FD27-9EC4-4206-9DCF-E38CB92FF43FQ53779452-EC53FA25-C7F8-4757-9B3E-4252565BA19E
P2860
Clinical pharmacokinetics of newer antiepileptic drugs. Lamotrigine, vigabatrin, gabapentin and oxcarbazepine.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Clinical pharmacokinetics of n ...... gabapentin and oxcarbazepine.
@en
type
label
Clinical pharmacokinetics of n ...... gabapentin and oxcarbazepine.
@en
prefLabel
Clinical pharmacokinetics of n ...... gabapentin and oxcarbazepine.
@en
P1476
Clinical pharmacokinetics of n ...... gabapentin and oxcarbazepine.
@en
P2093
P304
P356
10.2165/00003088-199630060-00001
P577
1996-06-01T00:00:00Z
P6179
1051328824